China's Geely Automobile Holdings and an oil group are seeking to take stakes in the fossil-fuel engine unit Renault, which plans to separate from its electric vehicle (EV) business.
Renault's alliance partner, Japanese carmaker Nissan, will not take a stake in the combustion engine unit.
Renault is expected to reveal plans for an EV-specific unit in France this autumn, as well as another in Europe that will bring together all of its petrol and hybrid engine and transmission production sites in Spain, Portugal, Turkey, Romania, and Latin America.
The French automaker intends to keep a majority stake in its "Ampère" electrical division, which will employ around 10,000 people and could go public in the second half of 2023.
However, it will retain only a minority stake in its "Horse" combustion engine business, which will employ a similar number of people but will remain a reference shareholder with significant clout in the unit.
According to sources, Renault would own 40 percent of the fossil-fuel engine unit, while Geely would own 40 percent and an oil company would own the remaining 20 percent.


Elon Musk’s Boring Company Raises $3 Billion at $23 Billion Valuation
Rise of the Zombie Bugs takes readers on a jaw-dropping tour of the parasite world
UK Food Inflation Forecast to Hit 6.4% by Mid-2027
Apple Unveils $1,999 Foldable iPhone Duo
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit
Norway Core Inflation Rises to 3% in August
Volkswagen Job Cuts Put Lower Saxony Leader Under Political Pressure
Thousands of satellites are due to burn up in the atmosphere every year – damaging the ozone layer and changing the climate
Asian Stocks Slide as Oil Surge Fuels Rate Hike Fears
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe
Extreme heat, flooding, wildfires – Colorado’s formerly incarcerated people on the hazards they faced behind bars
Anthropic Drops $6 Billion Decart AI Acquisition Talks
Ukraine minerals deal: the idea that natural resource extraction can build peace has been around for decades
Oil Prices Surge as Middle East Shipping Attacks Threaten Supply
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks 



